Alzheimer’s Drug Slows Cognitive Decline in Key Study

Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
By Rebecca Robbins and Pam Belluck from NYT Business https://ift.tt/NonQV3m
via IFTTT